To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.
NCT00170924 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 317
Last updated 2011-11-08
Summary
Patients who have had high blood pressure for a long time may have diastolic dysfunction. Diastolic Dysfunction is when your heart has difficulty filling and emptying, and relaxing adequately.
This study is to find out if Valsartan) will improve the ability of the heart to fill, empty, and relax appropriately when given alone or with other medicines to treat high blood pressure.
Conditions
- Diastolic Dysfunction
- Hypertension
Interventions
- DRUG
-
Valsartan
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2006-06-30
- Completion
- 2006-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00351130 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertension and Cardiovascular Risk Factors
NCT00171782 ·Status: COMPLETED ·Phase: PHASE4
-
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
NCT00902304 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
NCT00171054 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
NCT01001572 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
NCT00409643 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
NCT01912534 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.
NCT00409760 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
NCT00304226 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
NCT00171535 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
NCT00171353 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH
NCT03180593 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
NCT00294086 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.
NCT00171756 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone
NCT00171002 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
NCT00241137 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
NCT00171093 ·Status: COMPLETED ·Phase: PHASE3
-
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
NCT00931710 ·Status: COMPLETED ·Phase: PHASE4
-
A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension
NCT00170976 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4
-
Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
NCT00446524 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension
NCT00353912 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
NCT00170963 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
NCT00523744 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
NCT00241007 ·Status: COMPLETED ·Phase: PHASE3